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We report a light-sensitive histidine building block for 
Fmoc/tBu solid-phase peptide synthesis in which the 
imidazole side chain is coordinated to a ruthenium complex. 
We have applied this building block for the synthesis of 
caged-histidine peptides that can be readily deprotected by 
irradiation with visible light, and demonstrated the 
application of this approach for the photocontrol of the 
activity of Ni(II)-dependent peptide nucleases. 
Caged peptides are bioactive species that include a 
photocleavable protecting group masking a key functionality 
required for their action. Photolysis of the caging group releases 
the effector peptide,1 thus providing researchers with spatial 
and temporal control over biological processes.2,3 Peptides can 
be caged by modifications in their backbone,4 or by 
introduction of photolabile groups in specific amino acid side 
chains, including amines and carboxylates in Lys or Asp/Glu 
residues, thiols in cysteines, or hydroxyl groups in Ser, Thr and 
Tyr.5 Oddly enough, the photocontrol of biological processes 
with caged histidine peptides has not yet been described.6 This 
constitutes a significant gap in caging technology because 
histidine, although relatively uncommon in protein sequences 
(< 2,5%), is a highly versatile amino acid that plays key roles 
for the activity of many peptides and proteins, acting as an 
aromatic residue, a hydrogen bond donor or acceptor, or as a 
coordinating ligand,7 and can even suffer posttranslational 
modifications.8 Therefore, given the functional plasticity and 
biochemical relevance of this amino acid it would be highly 
relevant to develop a practical method for the synthesis of 
caged histidine peptide derivatives. 
 Most peptide caging approaches developed so far rely on 
the use of o-nitrobenzyl groups as photosensitive cleavable 
units.1,9 However, despite their wide application, these caging 
groups are not particularly suited for biological studies, because 
they require irradiation with harmful short-wavelength UV light 
for photolysis (about 365 nm).10 Therefore, there is a great 
interest in the development of substitute long-wavelength 
sensitive caging groups.11,12 In this context, photolabile 
bisbipyridyl ruthenium(II) complexes have been explored as 
alternative caging groups with promising spectroscopic 
properties (i.e. long photolysis wavelength and high uncaging 
quantum yields).13,14 With these premises, we decided to 
explore the application of ruthenium(II) bipyridyl complexes as 
photolabile protecting groups for caging histidine residues, 
anticipating that the coordination of the imidazole side chain 
with these complexes should effectively impair any peptide 
requiring the free imidazole for its activity. In addition to the 
spectroscopic advantages afforded by the use of Ru(II) 
complexes as caging groups, relying on the coordination of the 
pros nitrogen (Nε, Scheme 1) of the imidazole would also avoid 
potential synthetic problems related with the known tendency 
of Nδ to Nα acyl transfer during peptide elongation,15,16 as well 
as effectively block the metal-coordinating nitrogen in the 
imidazole side-chain. 
 The caged histidine building block, Fmoc–His(Ru)–OH (2), 
was efficiently synthesized in the two-step process outlined in 
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Scheme 1. In short, the commercially available cis-bis(2,2′-
bipyridine)dichloro ruthenium(II) complex (Ru(bpy)2Cl2) was 
treated with triphenylphosphine and then with Boc–His–OH in 
a one-pot reaction to yield the Boc-protected intermediate 1. 
Removal of the Boc protecting group with trifluoroacetic acid 
followed by installation of the Fmoc group with  
9-Fluorenylmethyl N-succinimidyl carbonate (Fmoc–OSu), 
afforded the desired Fmoc–His(Ru)–OH building block. The 
synthesis of the trimethylphosphine analog of 2 was also 
attempted following the same set of transformations,17 but 
deprotection of the Boc intermediate with TFA resulted in 
partial decomplexation of the histidine, which led us to focus 
our studies on the more stable triphenylphosphine derivative.  
 
 
Scheme 1. Synthesis of Fmoc–His(Ru)–OH. 
Before its incorporation into peptides, we determined the 
uncaging quantum yield of the Boc–His(Ru)–OH building 
block, which  was obtained by comparing its photolysis rate 
with that of  [Ru(bpy)2PPh3–GABA]
+ upon irradiation with a 
455 nm LED source (see the ESI).13c,18 The resulting uncaging 
quantum yield (Φunc ≈ 0.06) is comparable to the photolysis 
efficiency reported for other Ru(II)-photolabile 
compounds,13c,19 and of most organic cages.1c In addition to the 
expected uncaging of the histidine side chain and release of the 
side chain-deprotected Boc–His–OH, the HPLC analysis also 
showed the competitive cleavage of the PPh3 ligand as a minor 




complexes, possibly resulting from the reaction of the 
[Ru(bpy)2PPh3(H2O)]
+2 photolysis byproduct with the HPLC 
solvent system (see supporting information).20 The stability of 
the ruthenium cage in the presence of various potentially 
reactive species under physiological conditions (e.g. H2O2, 
histidine, glutathione), or competitive ions, such as nickel(II), 
was confirmed by HPLC after 24 h incubation (see the ESI). 
 Having at hand the desired building block and successfully 
demonstrated its photolabile properties, we tested its integration 
in standard solid phase peptide synthesis (SPPS) protocols by 
synthesizing a series of test peptides. Coupling of the caged 
histidine building block was conducted in all cases using 5 
equivalents of the Fmoc–His(Ru)–OH building block, and a 
mixture of HATU/HOAt (5 eq.) and DIEA (6 eq.) as base in 
DMF. The stereochemical integrity of the caged residue is 
maintained under those conditions, optimized to avoid 
epimerization of the Cα stereocenter (see supporting 
information). Cleavage of the resulting peptides with a standard 
acidic TFA cocktail (TFA : CH2Cl2 : triisopropylsilane : H2O : 
90 : 5 : 2.5 : 2.5),21 afforded in all cases the expected caged His 
peptides as major components in the crude samples (Fig. 1, 
left); only the synthesis of the longer peptide was problematic 
after the 15th coupling, resulting in the appearance significant 
secondary products, although the desired peptide was obtained 
as the major product of the synthesis (Fig. 1, left, trace c). 
 
Fig. 1 Left: normalized HPLC traces at 220 nm of crude mixtures 
resulting from the automated synthesis of test peptides. Purity (in 
brackets) was estimated from the area of the HPLC peaks. (a) 
HAKAEAEAKAK (86%); (b) WLAHKYLQGGC (92%); (c) 
LFQFLGKIIHHVGNFVHGFSHVF (46%). Right: representative 
peptide uncaging; bottom trace: crude peptide YEGKHSAEWG 
upper trace: HPLC after irradiation of the purified peptide, showing 
the uncaged peptide (d) and the ruthenium photolysis byproducts (*). 
H represents the caged histidine. 
Irradiation of the purified peptides with visible light resulted in 
all cases in complete uncaging and liberation of the unprotected 
parent peptides, as well as formation of the ruthenium 
photobyproducts (Fig. 1 right, and ESI). Furthermore, in 
contrast with the preliminary studies with the Boc–His(Ru)–OH 
building block, no photodissociation of the PPh3 group was 
observed in the uncaging of the peptides. 
 
Fig. 2 Uncaging of ©RGH peptide yields the metal-chelating RGH 
tripeptide, which displays nuclease activity in the form of a Ni(II) 
complex, RGH(Ni). 
As a simple model system in which to apply the newly 
developed photolabile histidine building block, we focused our 
attention on the Arg–Gly–His tripeptide (RGH), which has 
been described as an efficient metal-chelating sequence with 
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DNA binding and endonuclease properties in the presence of 
Ni(II) ions and oxidizing agents.22 Considering that the 
imidazole group in the histidine side chain is required for 
chelation of the Ni(II) ion, we reasoned that a caged histidine 
analog (©RGH) should be unable to coordinate the metal ion 
and form the catalytic metallopeptide. Furthermore, its nuclease 
activity should be recovered upon irradiation and uncaging of 
the histidine residue (Fig. 2). 
 Once we synthesized the ©RGH peptide following the 
procedures described before, we studied its uncaging: 
irradiation of a 10 µM solution of ©RGH in Na-cacodylate 
buffer at pH 7.5 for 1 min with a 455 nm LED source results in 
quantitative photolysis of the caged ©RGH peptide as shown 
by HPLC (Fig. 3 left, top trace); in addition to the peak 
corresponding to the uncaged peptide (RGH) that is eluted with 
the injection peak, we also observe the ruthenium complexes 
arising from the reaction of the photolyzed 
[Ru(bpy)2PPh3(H2O)]
+2 with the HPLC solvent system (Fig. 3 
left, top trace, peaks labeled with an asterisk). We next 
examined whether the uncaging event could trigger the 
nuclease activity of the ©RGH/RGH(Ni) system. Towards this 
end we incubated the pcDNA 3.1 Neo plasmid (as DNA 
substrate) with a mixture of 10 µM RGH and Ni(ClO4)2 and 
100 µM KHSO5 in Na-cacodylate buffer at pH 7.5 and 20 ºC 
for 15 min, and analyzed the resulting mixture with agarose 
electrophoresis. As expected, the band corresponding to the 
supercoiled DNA (Fig. 3, lane 1) is completely converted to a 
slower-migrating band, consistent with the formation of the 
nicked-circular form of the DNA (Fig. 3, lane 2). In contrast, 
the caged version of the peptide (©RGH) does not display 
nuclease activity under the same conditions (Fig. 3, lanes 3 and 
4). However, irradiation of ©RGH in the presence of the 
plasmid with visible light for just 1 min allowed the recovery of 
the nuclease activity, and the degradation of the DNA (Fig. 3, 
lanes 5 and 6). No degradation of the DNA band is observed in 
a control experiment when the amino acid Fmoc–His(Ru)–OH 
is irradiated in the same conditions (Fig. 3, lane 7), which 
confirms that the nuclease activity arises from the tripeptide 
Ni(II) complex, and not from the ruthenium complex or its 
photobyproducts (see the ESI). 
 
 
Fig. 3 Left: Uncaging of ©RGH monitored by HPLC. Bottom trace: 
caged peptide before photolysis; top trace: photolyzed mixture 
showing the complete disappearance of the caged peptide, and the 
formation of the ruthenium byproducts (*); the uncaged peptide is 
eluted with the injection peak (not shown). Right: Nuclease activity 
of ©RGH monitored by 1% agarose gel electrophoresis (see main 
text for reaction conditions). Lanes 1–7: 27.6 µg/mL of pcDNA 3.1 
Neo plasmid; lane 2: 10 µM of RGH and Ni(ClO4)2; lanes 3–4: 7.5 
and 10 µM of ©RGH and Ni(ClO4)2; lanes 5–6: 7.5 and 10 µM of 
©RGH and Ni(ClO4)2 after photolysis; lane 7: Fmoc–His(Ru)–OH 
(10 µM) and Ni(ClO4)2 after photolysis. Photolysis was carried out 
before addition of KHSO5 by irradiation at 455 nm for 1 min in the 
presence of the plasmid. 
 
Conclusions 
In summary, we describe the first effective caged histidine 
building block and its incorporation into peptides using 
standard Fmoc/tBu SPPS protocols. In contrast with common 
UV-sensitive o-nitrobenzyl groups, the photolabile Ru(II) 
bisbipyridyl complex can be efficiently removed using visible 
light. The potential of this approach was illustrated by 
controlling a metallopeptide nuclease, but it could be readily 
extended to other histidine-mediated interactions. 
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